Kadri Reis

Dr. Kadri Reis is a Researcher at the Peace Research Institute Frankfurt (PRIF), within the Research Department of International Security and the Research Group on Biological and Chemical Disarmament and Security. Her work bridges molecular biology and global security policy, focusing on biosecurity, dual-use technologies, and the governance of emerging biotechnologies.

She holds a PhD in Biomedicine from Pompeu Fabra University (2011–2016), an MSc in Molecular Bioengineering from TU Dresden (2007–2009), and a BA in Genetics from the University of Tartu, Estonia (2003–2007).

Her research interests include biosecurity, bioweapons, dual-use risks in genetic engineering, AI applications in biological risk assessment, and the policy implications of technological advancements in biotechnology. She actively contributes to the Cluster for Natural and Technical Science Arms Control Research (CNTR), producing policy-relevant analyses on topics such as oncolytic virus engineering and DNA synthesis screening.

Her recent publications span both technical genomics and security policy, revealing a dual trajectory: one in human genetics using large biobanks and GWAS, and another in science for nuclear and biological diplomacy. Themes across her work include ethical governance, risk mitigation, and the intersection of life sciences with international security.

• Dual-Use Risks of Oncolytic Virus Engineering (2024)
• Technological Implications of AI in Biorisk (2024)
• Implications of Technological Advancements for Biosecurity (2024)

Dr. Reis has been actively publishing in 2023 and 2024, with no mention of grants, students, or awards in the provided text. She is involved in interdisciplinary collaborations, particularly through the CNTR project, which connects scientific research with arms control policy. Her role emphasizes science-based policy development in the domain of biological threats.